722 results on '"Valley fever"'
Search Results
2. A Clinicopathological Categorization System for Clinical Research in Coccidioidomycosis
- Author
-
Krogstad, Paul, Thompson, George R, Heidari, Arash, Kuran, Rasha, Stephens, Alexis V, Butte, Manish J, and Johnson, Royce
- Subjects
Medical Microbiology ,Biomedical and Clinical Sciences ,Clinical Sciences ,Biodefense ,Infectious Diseases ,Orphan Drug ,Vaccine Related ,Rare Diseases ,Prevention ,Valley Fever ,Aetiology ,2.2 Factors relating to the physical environment ,Infection ,Good Health and Well Being ,coccidioidomycosis ,dissemination ,meningitis ,pathology ,valley fever ,Clinical sciences ,Medical microbiology - Abstract
A wide array of clinical manifestations follow infection with Coccidioides immitis or Coccidioides posadasii, ranging from asymptomatic infection to life-threatening pulmonary disease or extrapulmonary dissemination and meningitis. Epidemiological studies require consistent definitions of cases and their comparative clinical features. Understanding host and pathogen determinants of the severity of coccidioidomycosis also requires that specific clinical features (such as coccidioidal meningitis) and their overlap be precisely defined and quantified. Here we propose a system for categorization of outcomes of coccidioidomycosis in individuals who are not overtly immunocompromised that harmonizes clinical assessments during translational research of this increasingly common disease.
- Published
- 2023
3. Lupus Erythematosus Tumidus Misdiagnosed as Erythema Nodosum from Coccidioidomycosis
- Author
-
Brianae Garcia, Anis Hasnaoui, and Prakash V.A.K. Ramdass
- Subjects
lupus erythematosus tumidus ,coccidioidomycosis ,erythema nodosum ,valley fever ,misdiagnosis ,Dermatology ,RL1-803 - Abstract
Introduction: Lupus erythematosus tumidus (LET) is a rare photosensitive dermatosis that is categorized as intermittent cutaneous lupus erythematosus. It shares clinical similarities and histopathological features with other skin disorders, such as erythema nodosum, lymphocytic infiltrate of Jessner, and reticular erythematous mucinosis, thus making diagnosis quite challenging. We present a patient with LET whose diagnosis was confirmed after seeing several doctors. Case Presentation: A 52-year-old Hispanic female presented with tender erythematous nodules on her thighs for approximately 1 month. She was suspected of having erythema nodosum secondary to coccidioidomycosis and was prescribed fluconazole 200 mg for 30 days but showed no improvement. However, histopathological and direct immunofluorescence tests later confirmed a diagnosis of LET. The patient was treated with hydroxychloroquine, and the lesions improved remarkably after 2 weeks. Conclusion: LET is a rare dermatosis that closely resembles other dermatologic conditions such as erythema nodosum, lymphocytic infiltrate of Jessner, and reticular erythematous mucinosis. Diagnosis based on clinical features alone should be avoided, and ideally, treatment should only be initiated after confirmatory histopathological testing.
- Published
- 2024
- Full Text
- View/download PDF
4. Coccidioidomycosis-Related Hospital Visits, Texas, USA, 2016–2021
- Author
-
Heather Mayfield, Vanora Davila, and Elena Penedo
- Subjects
coccidioidomycosis ,Coccidioides immitis infection ,Coccidioides posadasii infection ,Valley fever ,fungi ,respiratory infections ,Medicine ,Infectious and parasitic diseases ,RC109-216 - Abstract
We analyzed hospital discharge records of patients with coccidioidomycosis-related codes from the International Classification of Diseases, 10th revision, Clinical Modification, to estimate the prevalence of hospital visits associated with the disease in Texas, USA. Using Texas Health Care Information Collection data for 2016–2021, we investigated the demographic characteristics and geographic distribution of the affected population, assessed prevalence of hospital visits for coccidioidomycosis, and examined how prevalence varied by demographic and geographic factors. In Texas, 709 coccidioidomycosis-related inpatient and outpatient hospital visits occurred in 2021; prevalence was 3.17 cases per 100,000 total hospital visits in 2020. Geographic location, patient sex, and race/ethnicity were associated with increases in coccidioidomycosis-related hospital visits; male, non-Hispanic Black, and Hispanic patients had the highest prevalence of coccidioidomycosis compared with other groups. Increased surveillance and healthcare provider education and outreach are needed to ensure timely and accurate diagnosis and treatment of coccidioidomycosis in Texas and elsewhere.
- Published
- 2024
- Full Text
- View/download PDF
5. Two lateral flow assays for detection of anti-coccidioidal antibodies show similar performance to immunodiffusion in dogs with coccidioidomycosis.
- Author
-
Grill, Francisca J., Jaffey, Jared A., Grys, Thomas E., Rayhe, Laura H., and Lake, Douglas F.
- Subjects
- *
COCCIDIOIDOMYCOSIS , *IMMUNOGLOBULINS , *IMMUNODIFFUSION , *DETECTOR dogs , *ANTIBODY titer - Abstract
OBJECTIVE To compare 2 point-of-care lateral flow assays (LFAs) with immunodiffusion (ID) IgG results for anti-coccidioidal antibody detection in dogs with coccidioidomycosis. A further aim was to compare the quantifiable output of 1 of the LFAs to ID antibody titers. SAMPLE Serum banked from 73 client-owned dogs diagnosed with pulmonary or disseminated coccidioidomycosis. METHODS ID was used to determine antibody presence and titer against a coccidioidal antigen preparation. All sera were subsequently tested on an LFA based on recombinant chitinase 1 (CTS1) and the commercially available sōna LFA. LFA results were analyzed and compared to ID IgG results and clinical diagnosis. RESULTS All assays showed similar sensitivities in detecting anti-coccidioidal antibodies (83.6% to 89.0%). When compared with ID IgG, the CTS1 LFA had a positive percent agreement of 100%, while the sōna LFA had a positive percent agreement of 91.4%. Since the CTS1 LFA is semiquantitative, we were able to compare test line densities with ID titers and found a strong correlation between the 2 assays (Spearman ρ = 0.82). CLINICAL RELEVANCE This is the first side-by-side evaluation of a commercially available LFA (sōna) and a newer more rapid anti-CTS1 antibody LFA using serum from dogs with coccidioidomycosis. Both LFAs tested have similar sensitivity to ID IgG results. The CTS1 LFA can be read after 10 minutes and is semiquantitative, while the sōna LFA is read after 30 minutes, and the results are subject to interpretation. Accurate and fast detection of anti-coccidioidal antibodies allows clinicians to initiate appropriate treatment without diagnostic delay. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Discovery of a Unique Set of Dog-Seroreactive Coccidioides Proteins Using Nucleic Acid Programmable Protein Array.
- Author
-
Koehler, Megan A., Song, Lusheng, Grill, Francisca J., Shubitz, Lisa F., Powell, Daniel A., Galgiani, John N., Orbach, Marc J., Robb, Edward J., Chung, Yunro, Williams, Stacy A., Murugan, Vel, Park, Jin-gyoon, LaBaer, Joshua, Lake, Douglas F., and Magee, D. Mitchell
- Subjects
- *
PROTEIN microarrays , *NUCLEIC acids , *COCCIDIOIDOMYCOSIS , *EXTRACELLULAR matrix proteins , *PROTEINS , *IMMUNOGLOBULINS - Abstract
Valley Fever (VF), caused by fungi in the genus Coccidioides, is a prevalent disease in southwestern and western parts of the United States that affects both humans and animals, such as dogs. Although the immune responses to infection with Coccidioides spp. are not fully characterized, antibody-detection assays are used in conjunction with clinical presentation and radiologic findings to aid in the diagnosis of VF. These assays often use Complement Fixation (CF) and Tube Precipitin (TP) antigens as the main targets of IgG and IgM reactivity, respectively. Our group previously reported evidence of over 800 genes expressed at the protein level in C. posadasii. However, antibody reactivity to the majority of these proteins has never been explored. Using a new, high-throughput screening technology, the Nucleic Acid Programmable Protein Array (NAPPA), we screened serum specimens from dogs against 708 of these previously identified proteins for IgG reactivity. Serum from three separate groups of dogs was analyzed and revealed a small panel of proteins to be further characterized for immuno-reactivity. In addition to CF/CTS1 antigen, sera from most infected dogs showed antibody reactivity to endo-1,3-betaglucanase, peroxisomal matrix protein, and another novel reactive protein, CPSG_05795. These antigens may provide additional targets to aid in antibody-based diagnostics. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Isavuconazole in the Treatment of Chronic Forms of Coccidioidomycosis.
- Author
-
Sharma, Rupam, Shakir, Qusai, Shah, Madiha, Clement, Josh, Donnelley, Monica, Reynolds, Trina, Trigg, Kate, Jolliff, Jeff, Kuran, Rasha, Johnson, Royce, Thompson, George, and Heidari, Arash
- Subjects
Coccidioides ,Valley fever ,antifungal ,isavuconazonium ,treatment ,Humans ,Coccidioidomycosis ,Coccidioides ,Triazoles ,Antifungal Agents - Abstract
Coccidioidomycosis is a fungal infection with a range of clinical manifestations. Currently used antifungal agents exhibit variable efficacy and toxicity profiles that necessitate evaluation of additional therapeutic options. Improvement was observed in the majority of patients treated with isavuconazole, with clinical failures observed only in those with coccidioidal meningitis.
- Published
- 2023
8. Differentiating Lung Nodules Due to Coccidioides from Those Due to Lung Cancer Based on Radiographic Appearance.
- Author
-
Peterson, Michael W, Jain, Ratnali, Hildebrandt, Kurt, Carson, William Keith, and Fayed, Mohamed A
- Subjects
chest CT scan ,cocci nodule ,incidental nodule ,lung cancer ,lung cancer screening ,lung nodule ,pulmonary coccidioidomycosis ,valley fever ,Cancer ,Prevention ,Lung Cancer ,Biomedical Imaging ,Lung - Abstract
BackgroundCoccidioidomycosis (cocci) is an endemic fungal disease that can cause asymptomatic or post-symptomatic lung nodules which are visible on chest CT scanning. Lung nodules are common and can represent early lung cancer. Differentiating lung nodules due to cocci from those due to lung cancer can be difficult and lead to invasive and expensive evaluations.Materials and methodsWe identified 302 patients with biopsy-proven cocci or bronchogenic carcinoma seen in our multidisciplinary nodule clinic. Two experienced radiologists who were blinded to the diagnosis read the chest CT scans and identified radiographic characteristics to determine their utility in differentiating lung cancer nodules from those due to cocci.ResultsUsing univariate analysis, we identified several radiographic findings that differed between lung cancer and cocci infection. We then entered these variables along with age and gender into a multivariate model and found that age, nodule diameter, nodule cavitation, presence of satellite nodules and radiographic presence of chronic lung disease differed significantly between the two diagnoses. Three findings, cavitary nodules, satellite nodules and chronic lung disease, have sufficient discrimination to potentially be useful in clinical decision-making.ConclusionsCareful evaluation of the three obtained radiographic findings can significantly improve our ability to differentiate benign coccidioidomycosis infection from lung cancer in an endemic region for the fungal disease. Using these data may significantly reduce the cost and risk associated with distinguishing the cause of lung nodules in these patients by preventing unnecessary invasive studies.
- Published
- 2023
9. Review of Clinical and Laboratory Diagnostics for Coccidioidomycosis.
- Author
-
McHardy, Ian, Barker, Bridget, and Thompson, George
- Subjects
Coccidioides ,antibody ,antigen ,coccidioidomycosis ,complement fixation ,diagnostics ,enzyme immunoassay ,fungus ,immunodiffusion ,serology ,valley fever ,Humans ,Coccidioidomycosis ,Coccidioides ,Antibodies ,Fungal ,Biological Assay - Abstract
Coccidioidomycosis is a fungal disease associated with soil exposure that frequently goes undiagnosed due at least in part to its nonspecific presentation and the lack of clinical suspicion by health care providers. Currently available diagnostics for coccidioidomycosis offer qualitative results that can suffer from low specificity, while semiquantitative assays are labor-intensive and complex and can require multiple days to complete. Furthermore, significant confusion exists regarding the optimal diagnostic algorithms and appropriate usage of available diagnostic tests. This review aims to inform clinical laboratorians and treating clinicians about the current diagnostic landscape, appropriate diagnostic strategies, and future diagnostic directions for coccidioidomycosis, which is expected to become more prevalent due to increased migration into areas of endemicity and climate changes.
- Published
- 2023
10. In vitro small molecule screening to inform novel candidates for use in fluconazole combination therapy in vivo against Coccidioides
- Author
-
Heather L. Mead, Michael Valentine, Holly Yin, George R. Thompson III, Paul Keim, David M. Engelthaler, and Bridget M. Barker
- Subjects
coccidioidomycosis ,Valley Fever ,antifungal therapy ,fungal infection ,adjunctive agent ,Microbiology ,QR1-502 - Abstract
ABSTRACT Identifying improved treatments for severe and refractory coccidioidomycosis (Valley fever) is needed. This endemic fungal disease is common in North and South America, and cases have increased substantially over the last 30 years. The current standard of care, oral daily fluconazole, often fails to completely eradicate Coccidioides infection; however, the high cost of identifying new compounds effective in treating Valley fever is a barrier to improving treatment. Therefore, repurposing existing pharmaceutical agents in combination with fluconazole therapy is an attractive option. We screened the Library of Pharmacologically Active Compounds (LOPAC) small molecule library for compounds that inhibited fungal growth in vitro and determined IC50 values for a subset of compounds. Based on these findings, we tested a small subset of these agents to validate the screen, as well as to test the performance of fluconazole in a combination therapy approach, as compared with fluconazole alone, in a murine model. We observed that combination therapy of tamoxifen:fluconazole and sertraline:fluconazole significantly reduced the burden of live fungus in the lung compared with fluconazole alone, and we observed reduced or nonexistent dissemination. These results suggest that tamoxifen and sertraline may be repurposed as adjunctive agents in the treatment of this important fungal disease.IMPORTANCEDeveloping new drugs, especially for regional orphan diseases, such as Valley Fever, is a slow and costly endeavor. However, there is a wealth of FDA-approved drugs available for repurposing, offering a more economical and expedited approach to improve treatment. Those existing compounds with antifungal properties can become novel therapies with relative ease: a considerable advantage for patients in need of alternative treatment. Despite the scope of remaining tasks, our comprehensive screening of potential candidates has revealed promising combinations for further exploration. This effort outlines a practical pipeline for Valley fever drug screening and identifies viable drug combinations that could impact patients more rapidly than single drug development pathways.
- Published
- 2024
- Full Text
- View/download PDF
11. Association between wildfires and coccidioidomycosis incidence in California, 2000–2018: a synthetic control analysis
- Author
-
Phillips, Sophie, Jones, Isabel, Sondermyer-Cooksey, Gail, Yu, Alexander T, Heaney, Alexandra K, Zhou, Bo, Bhattachan, Abinash, Weaver, Amanda K, Campo, Simon K, Mgbara, Whitney, Wagner, Robert, Taylor, John, Lettenmaier, Dennis, Okin, Gregory S, Jain, Seema, Vugia, Duc, Remais, Justin V, and Head, Jennifer R
- Subjects
Agricultural ,Veterinary and Food Sciences ,Ecological Applications ,Environmental Sciences ,Emerging Infectious Diseases ,Biodefense ,Valley Fever ,Infectious Diseases ,Rare Diseases ,California ,Climate change ,Coccidioidomycosis ,Coccidioides ,Drought ,Synthetic control ,Valley fever ,Wildfires - Abstract
The frequency and severity of wildfires in the Western United States have increased over recent decades, motivating hypotheses that wildfires contribute to the incidence of coccidioidomycosis, an emerging fungal disease in the Western United States with sharp increases in incidence observed since 2000. While coccidioidomycosis outbreaks have occurred among wildland firefighters clearing brush, it remains unknown whether fires are associated with an increased incidence among the general population.MethodsWe identified 19 wildfires occurring within California's highly endemic San Joaquin Valley between 2003 and 2015. Using geolocated surveillance records, we applied a synthetic control approach to estimate the effect of each wildfire on the incidence of coccidioidomycosis among residents that lived within a hexagonal buffer of 20 km radii surrounding the fire.ResultsWe did not detect excess cases due to wildfires in the 12 months (pooled estimated percent change in cases: 2.8%; 95% confidence interval [CI] = -29.0, 85.2), 13-24 months (7.9%; 95% CI = -27.3, 113.9), or 25-36 months (17.4%; 95% CI = -25.1, 157.1) following a wildfire. When examined individually, we detected significant increases in incidence following three of the 19 wildfires, all of which had relatively large adjacent populations, high transmission before the fire, and a burn area exceeding 5,000 acres.DiscussionWe find limited evidence that wildfires drive increases in coccidioidomycosis incidence among the general population. Nevertheless, our results raise concerns that large fires in regions with ongoing local transmission of Coccidioides may be associated with increases in incidence, underscoring the need for field studies examining Coccidioides spp. in soils and air pre- and post-wildfires.
- Published
- 2023
12. Asymptomatic Coccidioidal Meningitis Relapse: A Demon in Disguise
- Author
-
Kooner, Lovedip, Heidari, Arash, and Johnson, Royce
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Rare Diseases ,Neurosciences ,Male ,Humans ,Middle Aged ,Coccidioidomycosis ,Coccidioides ,Meningitis ,Fungal ,Meningitis ,Recurrence ,coccidioidal meningitis ,coccidioidomycosis ,meningitis ,valley fever ,coccidioidal meningitis relapse ,meningitis relapse - Abstract
Coccidioides spp is a soil-dwelling, dimorphic fungus that causes coccidioidomycosis. It is endemic to the western hemisphere. Although primarily a respiratory disease, it can also cause a myriad of clinical manifestations, from asymptomatic disease to meningitis. In fact, Coccidioides species is probably the most common etiologic agent of long-term meningitis in California and Arizona. Early diagnosis and treatment are critical to avoid fatal complications. With treatment, the cerebral spinal fluid analysis may return to normal. Relapse of coccidioidal meningitis is usually suspected with recurrence of meningitis symptoms. The patient is a 53-year-old man with a 2-decade history of coccidioidal meningitis who was diagnosed with an asymptomatic relapse of coccidioidal meningitis.
- Published
- 2023
13. Coccidioidal Pulmonary Cavitation: A New Age
- Author
-
Kooner, Lovedip, Munoz, Augustine, Garcia, Austin, Kaur, Akriti, Sharma, Rupam, Bustamante, Virginia, Narang, Vishal, Thompson, George R, Kuran, Rasha, Berjis, Amir, Johnson, Royce H, and Heidari, Arash
- Subjects
Microbiology ,Biological Sciences ,Rare Diseases ,Prevention ,Vaccine Related ,Biodefense ,Lung ,2.4 Surveillance and distribution ,Aetiology ,Respiratory ,coccidioidomycosis ,valley fever ,cavity ,cavitation ,cavitary ,coccidioidal - Abstract
Coccidioides species are thermally dimorphic fungi found in geographically defined areas of the Western Hemisphere. The primary portal of entry is respiratory, with symptomatic pneumonic diseases as the most common presentation. Subsequent pulmonary complications as well as extrapulmonary metastatic infection may occur, either of which may be the presenting disease manifestation. Cavitary lung disease may be found incidentally or when investigating symptoms such as cough or hemoptysis. This study aims to explore the spectrum of coccidioidal cavities and the evaluation and management in a cohort of patients seen at Kern Medical over the last 12 years.
- Published
- 2023
14. Coccidioides undetected in soils from agricultural land and uncorrelated with time or the greater soil fungal community on undeveloped land
- Author
-
Wagner, Robert, Montoya, Liliam, Head, Jennifer R, Campo, Simon, Remais, Justin, and Taylor, John W
- Subjects
Microbiology ,Biological Sciences ,Ecology ,Rare Diseases ,Prevention ,Valley Fever ,Life on Land ,Animals ,Coccidioides ,Coccidioidomycosis ,Soil ,Mycobiome ,Dust ,Rodentia ,Immunology ,Medical Microbiology ,Virology ,Medical microbiology - Abstract
Coccidioidomycosis is a typically respiratory fungal disease that, in the United States, occurs primarily in Arizona and California. In California, most coccidioidomycosis cases occur in the San Joaquin Valley, a primarily agricultural region where the disease poses a risk for outdoor workers. We collected 710 soil samples and 265 settled dust samples from nine sites in the San Joaquin Valley and examined how Coccidioides detection varied by month, site, and the presence and abundance of other fungal species. We detected Coccidioides in 89 of 238 (37.4%) rodent burrow soil samples at five undeveloped sites and were unable to detect Coccidioides in any of 472 surface and subsurface soil samples at four agricultural sites. In what is the largest sampling effort undertaken on agricultural land, our results provide no evidence that agricultural soils in the San Joaquin Valley harbor Coccidioides. We found no clear association between Coccidioides and the greater soil fungal community, but we identified 19 fungal indicator species that were significantly associated with Coccidioides detection in burrows. We also did not find a seasonal pattern in Coccidioides detection in the rodent burrow soils we sampled. These findings suggest both the presence of a spore bank and that coccidioidomycosis incidence may be more strongly associated with Coccidioides dispersal than Coccidioides growth. Finally, we were able to detect Coccidioides in only five of our 265 near-surface settled dust samples, one from agricultural land, where Coccidioides was undetected in soils, and four from undeveloped land, where Coccidioides was common in the rodent burrow soils we sampled. Our ability to detect Coccidioides in few settled dust samples indicates that improved methods are likely needed moving forward, though raises questions regarding aerial dispersal in Coccidioides, whose key transmission event likely occurs over short distances in rodent burrows from soil to naïve rodent lungs.
- Published
- 2023
15. Galleria mellonella Model of Coccidioidomycosis for Drug Susceptibility Tests and Virulence Factor Identification.
- Author
-
Mendoza Barker, Matthew, Saeger, Sarah, Campuzano, Althea, Yu, Jieh-Juen, and Hung, Chiung-Yu
- Subjects
- *
GREATER wax moth , *COCCIDIOIDOMYCOSIS , *RESPIRATORY diseases , *LARVAE , *IMMUNE system - Abstract
Coccidioidomycosis (CM) can manifest as respiratory and disseminated diseases that are caused by dimorphic fungal pathogens, such as Coccidioides species. The inhaled arthroconidia generated during the saprobic growth phase convert into multinucleated spherules in the lungs to complete the parasitic lifecycle. Research on coccidioidal virulence and pathogenesis primarily employs murine models typically associated with low lethal doses (LD100 < 100 spores). However, the Galleria model has recently garnered attention due to its immune system bearing both structural and functional similarities to the innate system of mammals. Our findings indicate that Coccidioides posadasii can convert and complete the parasitic cycle within the hemocoel of the Galleria larva. In Galleria, the LD100 is between 0.5 and 1.0 × 106 viable spores for the clinical isolate Coccidioides posadasii C735. Furthermore, we demonstrated the suitability of this model for in vivo antifungal susceptibility tests to validate the bioreactivity of newly discovered antifungals against Coccidioides. Additionally, we utilized this larva model to screen a Coccidioides posadasii mutant library showing attenuated virulence. Similarly, the identified attenuated coccidioidal mutants displayed a loss of virulence in a commonly used murine model of coccidioidomycosis. In this study, we demonstrated that Galleria larvae can be applied as a model for studying Coccidioides infection. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Serial evaluation of liver enzyme activities in dogs with pulmonary coccidioidomycosis administered per os fluconazole
- Author
-
Dena Berlin, Jared A. Jaffey, Charlotte Bolch, Tian Zhou, Laura H. Rayhel, and Andrew S. Hanzlicek
- Subjects
hepatotoxicity ,antifungal ,valley fever ,Coccidioides ,fluconazole ,Veterinary medicine ,SF600-1100 - Abstract
Pulmonary coccidioidomycosis is a relatively common fungal disorder in dogs that have lived in or traveled to endemic regions and fluconazole is a common antifungal treatment. Liver enzymopathy can occur with fluconazole administration, but the frequency of occurrence nor potentially associative factors have been explored in dogs with pulmonary coccidioidomycosis. Therefore, our objectives were to describe the occurrence and magnitude of liver enzyme activity (LEA) elevation in dogs with pulmonary coccidioidomycosis during treatment with per os fluconazole and identify variables associated with liver enzymopathy. This was a retrospective observational study that analyzed serum biochemical data obtained from a separate prospective study that included 32 client-owned dogs with newly diagnosed pulmonary coccidioidomycosis from October 2020 to February 2021. Per os fluconazole administration (median dosage: 16.2 mg/kg/day) was initiated after diagnosis and dogs were evaluated once every 3 months thereafter until remission or for a maximum of 12 months. Recorded biochemical parameters at each visit (including baseline) included alanine transaminase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and gamma-glutamyl transferase (GGT). Magnitude of increased LEA was based on the fold increase above the upper limit of the reference interval and defined as mild (10×). Forty-seven percent (15/32) of dogs were documented to have elevations in one or more LEAs after initiation of fluconazole administration during the study period. Thirty-four percent and 25% of dogs had elevated ALP and ALT activities, respectively, at some point during treatment. Elevations in AST and GGT activities were rare. The magnitude of LEA elevation was mild in all cases. Logistic regression models did not identify associations between age, weight, sex, neutered status, prednisone administration, fluconazole dose or duration of treatment with the occurrence of liver enzymopathy. Approximately half of dogs with pulmonary coccidioidomycosis are expected to develop mild increases in activities of ALP and/or ALT with rare involvement of AST or GGT at some point during treatment with fluconazole up to 12 months.
- Published
- 2024
- Full Text
- View/download PDF
17. Examining Miliary Disease Etiology in a Coccidioides -Endemic Center: A Retrospective Cohort Study.
- Author
-
Scott, Ashley M., Lim, James Ray, Randhawa, Reubender, Lee, Jason, Yaddanapudi, Kavitha, Rabe, Brooke, and Malo, Joshua
- Subjects
- *
ETIOLOGY of diseases , *COCCIDIOIDOMYCOSIS , *COHORT analysis , *METASTASIS , *EOSINOPHILIA , *RESEARCH questions , *CETUXIMAB - Abstract
Background: A miliary pattern on chest imaging is often attributed to tuberculosis (TB) infection. However, a myriad of conditions can cause a miliary pattern, many of which are imminently life-threatening. Research Question: The primary aim of our study is to elucidate the potential causes of miliary chest imaging patterns to improve workup and empiric therapy selection. The secondary aims are to discern the predictors of miliary disease etiology and to determine whether appropriate empiric antimicrobial therapies were given. Study Design and Methods: In this retrospective cohort study, we searched a radiology database for patients with chest imaging studies described by the word "miliary". Subjects were excluded if they were under 18 years of age and if there were insufficient objective data to support a miliary disease etiology. A radiologist independently reviewed all imaging studies, and studies that did not appear to have a true miliary pattern were excluded. The collected data include patient demographics, immunocompromising risk factors, conditions associated with miliary disease, β-D-glucan levels, serum eosinophil count, and empiric therapies received. Results: From our 41-patient cohort, 22 patients (53.7%) were clinically diagnosed with coccidioidomycosis, 8 (19.5%) with TB, 7 (17.1%) with metastatic solid cancer, 1 (2.4%) with lymphoma, 1 (2.4%) with other (Mycobacterium simiae), and 3 (7.3%) with unknown diseases (the sum equals 42 patients because one individual was diagnosed with both coccidioidomycosis and TB). All six patients with greater than 500 eosinophils/μL were diagnosed with coccidioidomycosis. Of the 22 patients diagnosed with coccidioidomycosis, 20 (90.91%) were empirically treated with an antifungal regimen. Of the eight patients with TB, six were empirically treated for TB. Interpretation: Based on our data from a Coccidioides-endemic region with close proximity to tuberculosis-endemic areas, the leading cause of miliary disease is coccidioidomycosis, although TB and cancer are also common etiologies. Serum eosinophilia and elevated β-D-glucan levels were strongly predictive of coccidioidomycosis in our patient cohort with a miliary chest imaging pattern. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Lupus Erythematosus Tumidus Misdiagnosed as Erythema Nodosum from Coccidioidomycosis.
- Author
-
Garcia, Brianae, Hasnaoui, Anis, and Ramdass, Prakash V.A.K.
- Subjects
- *
ERYTHEMA nodosum , *LUPUS erythematosus , *COCCIDIOIDOMYCOSIS , *HISPANIC American women , *DELAYED diagnosis , *PYODERMA gangrenosum - Abstract
Introduction: Lupus erythematosus tumidus (LET) is a rare photosensitive dermatosis that is categorized as intermittent cutaneous lupus erythematosus. It shares clinical similarities and histopathological features with other skin disorders, such as erythema nodosum, lymphocytic infiltrate of Jessner, and reticular erythematous mucinosis, thus making diagnosis quite challenging. We present a patient with LET whose diagnosis was confirmed after seeing several doctors. Case Presentation: A 52-year-old Hispanic female presented with tender erythematous nodules on her thighs for approximately 1 month. She was suspected of having erythema nodosum secondary to coccidioidomycosis and was prescribed fluconazole 200 mg for 30 days but showed no improvement. However, histopathological and direct immunofluorescence tests later confirmed a diagnosis of LET. The patient was treated with hydroxychloroquine, and the lesions improved remarkably after 2 weeks. Conclusion: LET is a rare dermatosis that closely resembles other dermatologic conditions such as erythema nodosum, lymphocytic infiltrate of Jessner, and reticular erythematous mucinosis. Diagnosis based on clinical features alone should be avoided, and ideally, treatment should only be initiated after confirmatory histopathological testing. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. A Recombinant Multivalent Vaccine (rCpa1) Induces Protection for C57BL/6 and HLA Transgenic Mice against Pulmonary Infection with Both Species of Coccidioides.
- Author
-
Campuzano, Althea, Pentakota, Komali Devi, Liao, Yu-Rou, Zhang, Hao, Wiederhold, Nathan P., Ostroff, Gary R., and Hung, Chiung-Yu
- Subjects
TRANSGENIC mice ,LUNG infections ,DNA sequencing ,CIS-regulatory elements (Genetics) ,LABORATORY mice ,VACCINES ,MYCOBACTERIA ,MATERNALLY acquired immunity - Abstract
Coccidioidomycosis is caused by Coccidioides posadasii (Cp) and Coccidioides immitis (Ci), which have a 4–5% difference in their genomic sequences. There is an urgent need to develop a human vaccine against both species. A previously created recombinant antigen (rCpa1) that contains multiple peptides derived from Cp isolate C735 is protective against the autologous isolate. The focus of this study is to evaluate cross-protective efficacy and immune correlates by the rCpa1-based vaccine against both species of Coccidioides. DNA sequence analyses of the homologous genes for the rCpa1 antigen were conducted for 39 and 17 clinical isolates of Cp and Ci, respectively. Protective efficacy and vaccine-induced immunity were evaluated for both C57BL/6 and human HLA-DR4 transgenic mice against five highly virulent isolates of Cp and Ci. There are total of seven amino acid substitutions in the rCpa1 antigen between Cp and Ci. Both C57BL/6 and HLA-DR4 mice that were vaccinated with an rCpa1 vaccine had a significant reduction of fungal burden and increased numbers of IFN-γ- and IL-17-producing CD4+ T cells in the first 2 weeks post challenge. These data suggest that rCpa1 has cross-protection activity against Cp and Ci pulmonary infection through activation of early Th1 and Th17 responses. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. A chromosomal-level reference genome of the widely utilized Coccidioides posadasii laboratory strain “Silveira”
- Author
-
de Melo Teixeira, Marcus, Stajich, Jason E, Sahl, Jason W, Thompson, George R, Brem, Rachel B, Dubin, Claire A, Blackmon, Austin V, Mead, Heather L, Keim, Paul, and Barker, Bridget M
- Subjects
Microbiology ,Biological Sciences ,Bioinformatics and Computational Biology ,Genetics ,Valley Fever ,Rare Diseases ,Human Genome ,Base Sequence ,Coccidioides ,Coccidioidomycosis ,Humans ,Phylogeny ,valley fever ,long-read sequencing ,funannotate ,human fungal pathogen ,fungal genomes ,reference genome ,coccidioidomycosis ,Biochemistry and cell biology ,Statistics - Abstract
Coccidioidomycosis is a common fungal disease that is endemic to arid and semi-arid regions of both American continents. Coccidioides immitis and Coccidioides posadasii are the etiological agents of the disease, also known as Valley Fever. For several decades, the C. posadasii strain Silveira has been used widely in vaccine studies, is the source strain for production of diagnostic antigens, and is a widely used experimental strain for functional studies. In 2009, the genome was sequenced using Sanger sequencing technology, and a draft assembly and annotation were made available. In this study, the genome of the Silveira strain was sequenced using single molecule real-time sequencing PacBio technology, assembled into chromosomal-level contigs, genotyped, and the genome was reannotated using sophisticated and curated in silico tools. This high-quality genome sequencing effort has improved our understanding of chromosomal structure, gene set annotation, and lays the groundwork for identification of structural variants (e.g. transversions, translocations, and copy number variants), assessment of gene gain and loss, and comparison of transposable elements in future phylogenetic and population genomics studies.
- Published
- 2022
21. Coccidioidomycosis Knowledge and Behaviors of California Hispanic Farm Workers
- Author
-
Sipan, Carol L, Portillo-Silva, Catherine, Bang, Heejung, and McCurdy, Stephen
- Subjects
Epidemiology ,Public Health ,Health Sciences ,Behavioral and Social Science ,Clinical Research ,Prevention ,Good Health and Well Being ,Decent Work and Economic Growth ,California ,Coccidioidomycosis ,Farmers ,Health Knowledge ,Attitudes ,Practice ,Hispanic or Latino ,Humans ,Male ,Occupational Exposure ,valley fever ,knowledge ,attitudes ,beliefs and behaviors ,prevention ,farm workers ,Agriculture ,Land and Farm Management ,Public Health and Health Services ,Policy and Administration ,Environmental & Occupational Health ,Public health - Abstract
(1) Describe knowledge, attitudes, beliefs, and behaviors related to coccidioidomycosis (Valley fever, VF) reported by farm workers in a highly endemic area to design and evaluate prevention messages and (2) identify health information sources preferred by farm workers to disseminate VF prevention messages. There were 119 primarily Mexican-born residents of two migrant farm labor housing centers in Kern County, who completed an interviewer-administered survey on VF knowledge, attitudes, beliefs, and behaviors in 2017. The 73% of participants aware of VF demonstrated a knowledge score of 53%. Over 90% erroneously believed VF was associated with pesticide exposure; approximately two-thirds believed that wearing a bandana mask was protective. Over half of respondents believed that VF was contagious, could be contracted from contaminated food or water, and caused gastrointestinal symptoms. Of those aware of VF, 75% expressed concern about becoming infected because of where they lived and working outdoors. Working outdoors in dusty conditions was the most commonly reported risk-associated work practice. Among 67 participants reporting use of respiratory protection, 94% indicated they wear a bandana; most male participants did not wear face coverings in dusty conditions. The most frequent protective work practice was wetting soil. Preferred sources of health information included television; family, friend, or co-worker; healthcare provider; and radio. Farm workers reported multiple risk factors for VF. Results identified several areas of poor knowledge, risk behavior, and preferred channels of prevention messages. Important protective behaviors are not under the control of farm workers; engagement with employers is essential.
- Published
- 2022
22. Pediatric coccidioidal orbital granuloma.
- Author
-
Bittencourt, Cassiana E, Okezie, Onyinye, Tawansy, Khalid, Peterson, Ellena M, and Minckler, Don S
- Subjects
Coccidioides spp. ,Coccidioidomycosis ,Granulomatous disease ,Orbit granuloma ,Valley fever ,Rare Diseases ,Clinical Research ,Biotechnology ,Pediatric ,Bioengineering - Abstract
PurposeTo report a case of orbital coccidiomycosis in an otherwise healthy 11-month-old male.ObservationsAn 11-month-old male presented to his pediatrician with parental complaints of swelling, erythema, and pain of the right orbit that increased over ten days in the absence of constitutional symptoms. The child's parents reported an earlier fall onto a carpeted floor. After four weeks of conservative treatment and a course of oral cephalexin, he developed a fever, increased erythema, and palpable enlargement of a mass posterior to the lower eyelid. Ultrasound revealed an encysted mass in the inferior orbit, suggestive of an abscess. Urgent ophthalmic referral led to incision and drainage via orbitotomy. Culture, histopathology, and serological testing were positive for Coccidioides spp.. Blood studies revealed mild anemia and thrombocytosis. There was complete resolution of symptoms after surgical drainage and several weeks of oral fluconazole.Conclusion and importanceWe describe a patient with orbital coccidiomycosis without apparent systemic involvement, following what was most likely an unrelated minor trauma. Despite being rare, orbital coccidiomycosis should be considered as a primary manifestation of infection when ocular inflammation is encountered, especially in endemic regions.
- Published
- 2022
23. Decoding Transcription Regulatory Mechanisms Associated with Coccidioides immitis Phase Transition Using Total RNA
- Author
-
Duttke, Sascha H, Beyhan, Sinem, Singh, Rajendra, Neal, Sonya, Viriyakosol, Suganya, Fierer, Joshua, Kirkland, Theo N, Stajich, Jason E, Benner, Christopher, and Carlin, Aaron F
- Subjects
Biological Sciences ,Bioinformatics and Computational Biology ,Biomedical and Clinical Sciences ,Microbiology ,Clinical Sciences ,Medical Microbiology ,Infectious Diseases ,Genetics ,Emerging Infectious Diseases ,Human Genome ,Biotechnology ,Biodefense ,Rare Diseases ,Valley Fever ,2.2 Factors relating to the physical environment ,Aetiology ,2.1 Biological and endogenous factors ,Infection ,Good Health and Well Being ,Humans ,Coccidioides ,Coccidioidomycosis ,Virulence ,Gene Expression Regulation ,RNA ,Transcription Factors ,Coccidioides immitis ,coccidioidomycosis ,valley fever ,WOPR ,csRNA-seq ,gene regulation ,genomics ,phase transition ,transcription factors ,transcriptomics - Abstract
New or emerging infectious diseases are commonly caused by pathogens that cannot be readily manipulated or studied under common laboratory conditions. These limitations hinder standard experimental approaches and our abilities to define the fundamental molecular mechanisms underlying pathogenesis. The advance of capped small RNA sequencing (csRNA-seq) now enables genome-wide mapping of actively initiated transcripts from genes and other regulatory transcribed start regions (TSRs) such as enhancers at a precise moment from total RNA. As RNA is nonpathogenic and can be readily isolated from inactivated infectious samples, csRNA-seq can detect acute changes in gene regulation within or in response to a pathogen with remarkable sensitivity under common laboratory conditions. Studying valley fever (coccidioidomycosis), an emerging endemic fungal infection that increasingly impacts livestock, pet, and human health, we show how csRNA-seq can unravel transcriptional programs driving pathogenesis. Performing csRNA-seq on RNA isolated from different stages of the valley fever pathogen Coccidioides immitis revealed alternative promoter usage, connected cis-regulatory domains, and a WOPR family transcription factor, which are known regulators of virulence in other fungi, as being critical for pathogenic growth. We further demonstrate that a C. immitis WOPR homologue, CIMG_02671, activates transcription in a WOPR motif-dependent manner. Collectively, these findings provide novel insights into valley fever pathogenesis and provide a proof of principle for csRNA-seq as a powerful means to determine the genes, regulatory mechanisms, and transcription factors that control the pathogenesis of highly infectious agents. IMPORTANCE Infectious pathogens like airborne viruses or fungal spores are difficult to study; they require high-containment facilities, special equipment, and expertise. As such, establishing approaches such as genome editing or other means to identify the factors and mechanisms underlying caused diseases, and, thus, promising drug targets, is costly and time-intensive. These obstacles particularly hinder the analysis of new, emerging, or rare infectious diseases. We recently developed a method termed capped small RNA sequencing (csRNA-seq) that enables capturing acute changes in active gene expression from total RNA. Prior to csRNA-seq, such an analysis was possible only by using living cells or nuclei, in which pathogens are highly infectious. The process of RNA purification, however, inactivates pathogens and thus enables the analysis of gene expression during disease progression under standard laboratory conditions. As a proof of principle, here, we use csRNA-seq to unravel the gene regulatory programs and factors likely critical for the pathogenesis of valley fever, an emerging endemic fungal infection that increasingly impacts livestock, pet, and human health.
- Published
- 2022
24. Breathing can be dangerous: Opportunistic fungal pathogens and the diverse community of the small mammal lung mycobiome
- Author
-
Salazar-Hamm, Paris S, Montoya, Kyana N, Montoya, Liliam, Cook, Kel, Liphardt, Schuyler, Taylor, John W, Cook, Joseph A, and Natvig, Donald O
- Subjects
Microbiology ,Biological Sciences ,Biomedical and Clinical Sciences ,Clinical Sciences ,Pneumonia & Influenza ,Infectious Diseases ,Lung Cancer ,Cancer ,Lung ,Coccidioides ,Valley fever ,Onygenales ,Blastomyces ,Aspergillus fumigatus ,Pneumocystis - Abstract
Human lung mycobiome studies typically sample bronchoalveolar lavage or sputum, potentially overlooking fungi embedded in tissues. Employing ultra-frozen lung tissues from biorepositories, we obtained fungal ribosomal RNA ITS2 sequences from 199 small mammals across 39 species. We documented diverse fungi, including common environmental fungi such as Penicillium and Aspergillus, associates of the human mycobiome such as Malassezia and Candida, and others specifically adapted for lungs (Coccidioides, Blastomyces, and Pneumocystis). Pneumocystis sequences were detected in 83% of the samples and generally exhibited phylogenetic congruence with hosts. Among sequences from diverse opportunistic pathogens in the Onygenales, species of Coccidioides occurred in 12% of samples and species of Blastomyces in 85% of samples. Coccidioides sequences occurred in 14 mammalian species. The presence of neither Coccidioides nor Aspergillus fumigatus correlated with substantial shifts in the overall mycobiome, although there was some indication that fungal communities might be influenced by high levels of A. fumigatus. Although members of the Onygenales were common in lung samples (92%), they are not common in environmental surveys. Our results indicate that Pneumocystis and certain Onygenales are common commensal members of the lung mycobiome. These results provide new insights into the biology of lung-inhabiting fungi and flag small mammals as potential reservoirs for emerging fungal pathogens.
- Published
- 2022
25. A Case of Thyroidal Coccidioidal Infection
- Author
-
Raza, Nadia and Heidari, Arash
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Rare Diseases ,Prevention ,Infectious Diseases ,Vaccine Related ,Biodefense ,Coccidioides ,Coccidioidomycosis ,Humans ,coccidioidomycosis ,valley fever ,fungal infection ,dissemination ,thyroid fungal infection - Abstract
Infection of the thyroid gland with Coccidioides immitis is rare. We report a case with disseminated coccidiomycosis involving thyroid gland as a thyroid nodule. Although historical autopsy studies have indicated that coccidioidal involvement of the thyroid gland can infrequently occur as part of disseminated infection, to our knowledge, only less than 10 other cases have been reported. Optimal treatment duration and dosage of medication are uncertain in literature of this rare involvement of thyroid gland with coccidioidomycosis.
- Published
- 2022
26. Pulmonary Giant Cavitary Coccidioides With Fungal Ball and Hemoptysis
- Author
-
Narang, Vishal K, Dao, Kevin, Jaratanian, Sara, D’Assumpcao, Carlos, Kuran, Rasha, Munoz, Augustine, and Heidari, Arash
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Infectious Diseases ,Valley Fever ,Lung ,Rare Diseases ,Infection ,Good Health and Well Being ,Coccidioides ,Coccidioidomycosis ,Hemoptysis ,Humans ,Lung Diseases ,Fungal ,infectious disease ,pulmonary critical care ,radiology/imaging - Abstract
Coccidioidomycosis (CM) is a fungal disease that results from inhalation of spores of Coccidioides immitis and C posadasii. If symptomatic, disease primarily manifests as community-acquired pneumonia; however, additional pulmonary manifestations such as pleural effusion, empyema, and cavitation may occur. Diabetic patients have an increased risk of severe and cavitary CM. Cavitary disease may erode vasculature and pulmonary parenchyma leading to further complications. Furthermore, chronic cavities can become colonized as well and develop superimposed infections. This is a case of cavitary CM in uncontrolled diabetic nonadherent to treatment presenting with hemoptysis and mycetoma.
- Published
- 2022
27. Disseminated Coccidioidomycosis: Cutaneous, Soft Tissue, Osseous, and “Shotgun Intraparenchymal” Brain Disease
- Author
-
Sharifi, Saman, Sharma, Rupam, Heidari, Arash, and Johnson, Royce H
- Subjects
Biological Sciences ,Biomedical and Clinical Sciences ,Clinical Sciences ,Neurosciences ,Orphan Drug ,Valley Fever ,Rare Diseases ,Brain Diseases ,Coccidioides ,Coccidioidomycosis ,Humans ,Skin ,Spores ,Fungal ,coccidioidomycosis ,valley fever ,dissemination ,fungal infection ,meningitis ,soft tissue infection - Abstract
Coccidioidomycosis is a disease found in the southwestern United States and caused by inhalation of arthroconidia of Coccidioides immitis and posadasii. Although the disease is most commonly asymptomatic or respiratory, it has a propensity to disseminate to any tissue in the body with the most common being skin, bone, joints, and central nervous system. This case demonstrates the dissemination of coccidioidomycosis to several foci along with a rare form of parenchymal dissemination with an unusual neuroradiological finding.
- Published
- 2022
28. The WOPR family protein Ryp1 is a key regulator of gene expression, development, and virulence in the thermally dimorphic fungal pathogen Coccidioides posadasii
- Author
-
Mandel, M Alejandra, Beyhan, Sinem, Voorhies, Mark, Shubitz, Lisa F, Galgiani, John N, Orbach, Marc J, and Sil, Anita
- Subjects
Microbiology ,Biological Sciences ,Infectious Diseases ,Valley Fever ,Emerging Infectious Diseases ,Biodefense ,Rare Diseases ,Genetics ,2.1 Biological and endogenous factors ,2.2 Factors relating to the physical environment ,Aetiology ,Infection ,Animals ,Coccidioides ,Fungal Proteins ,Gene Expression ,Mammals ,Mice ,Mice ,Inbred C57BL ,Spores ,Fungal ,Transcription Factors ,Virulence ,Immunology ,Medical Microbiology ,Virology ,Medical microbiology - Abstract
Coccidioides spp. are mammalian fungal pathogens endemic to the Southwestern US and other desert regions of Mexico, Central and South America, with the bulk of US infections occurring in California and Arizona. In the soil, Coccidioides grows in a hyphal form that differentiates into 3-5 micron asexual spores (arthroconidia). When arthroconidia are inhaled by mammals they undergo a unique developmental transition from polar hyphal growth to isotropic expansion with multiple rounds of nuclear division, prior to segmentation, forming large spherules filled with endospores. Very little is understood about the molecular basis of spherule formation. Here we characterize the role of the conserved transcription factor Ryp1 in Coccidioides development. We show that Coccidioides Δryp1 mutants have altered colony morphology under hypha-promoting conditions and are unable to form mature spherules under spherule-promoting conditions. We analyze the transcriptional profile of wild-type and Δryp1 mutant cells under hypha- and spherule-promoting conditions, thereby defining a set of hypha- or spherule-enriched transcripts ("morphology-regulated" genes) that are dependent on Ryp1 for their expression. Forty percent of morphology-regulated expression is Ryp1-dependent, indicating that Ryp1 plays a dual role in both hyphal and spherule development. Ryp1-dependent transcripts include key virulence factors such as SOWgp, which encodes the spherule outer wall glycoprotein. Concordant with its role in spherule development, we find that the Δryp1 mutant is completely avirulent in the mouse model of coccidioidomycosis, indicating that Ryp1-dependent pathways are essential for the ability of Coccidioides to cause disease. Vaccination of C57BL/6 mice with live Δryp1 spores does not provide any protection from lethal C. posadasii intranasal infection, consistent with our findings that the Δryp1 mutant fails to make mature spherules and likely does not express key antigens required for effective vaccination. Taken together, this work identifies the first transcription factor that drives mature spherulation and virulence in Coccidioides.
- Published
- 2022
29. Coccidioides Species: A Review of Basic Research: 2022
- Author
-
Kirkland, Theo N, Stevens, David A, Hung, Chiung-Yu, Beyhan, Sinem, Taylor, John W, Shubitz, Lisa F, Duttke, Sascha H, Heidari, Arash, Johnson, Royce H, Deresinski, Stanley C, Lauer, Antje, and Fierer, Joshua
- Subjects
Microbiology ,Biological Sciences ,Emerging Infectious Diseases ,Valley Fever ,Biodefense ,Infectious Diseases ,Rare Diseases ,Infection ,Coccidioides immitis ,Coccidioides posadasii ,coccidioidomycosis ,fungus ,dimorphic fungus ,mycelium ,spherule ,mycology ,microbiology ,pathogenesis - Abstract
Coccidioides immitis and posadasii are closely related fungal species that cause coccidioidomycosis. These dimorphic organisms cause disease in immunocompetent as well as immunocompromised individuals and as much as 40% of the population is infected in the endemic area. Although most infections resolve spontaneously, the infection can be prolonged and, in some instances, fatal. Coccidioides has been studied for more than 100 years and many aspects of the organism and the disease it causes have been investigated. There are over 500 manuscripts concerning Coccidioides (excluding clinical articles) referenced in PubMed over the past 50 years, so there is a large body of evidence to review. We reviewed the most accurate and informative basic research studies of these fungi including some seminal older studies as well as an extensive review of current research. This is an attempt to gather the most important basic research studies about this fungus into one publication. To focus this review, we will discuss the mycology of the organism exclusively rather than the studies of the host response or clinical studies. We hope that this review will be a useful resource to those interested in Coccidioides and coccidioidomycosis.
- Published
- 2022
30. A randomized, double-blind, placebo-controlled clinical trial of fluconazole as early empiric treatment of coccidioidomycosis pneumonia (Valley Fever) in adults presenting with community-acquired pneumonia in endemic areas (FLEET-Valley Fever)
- Author
-
Messina, Julia A, Maziarz, Eileen K, Galgiani, John, Truong, Jonathan T, Htoo, Aung K, Heidari, Arash, Johnson, Royce H, Narang, Aneesh T, Donovan, Fariba M, Ewell, Marion, Catanzaro, Antonino, Thompson, George R, Ampel, Neil M, Perfect, John R, Naggie, Susanna, and Walter, Emmanuel B
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Infectious Diseases ,Clinical Trials and Supportive Activities ,Prevention ,Vaccine Related ,Pneumonia ,Lung ,Biodefense ,Emerging Infectious Diseases ,Clinical Research ,6.1 Pharmaceuticals ,Evaluation of treatments and therapeutic interventions ,Infection ,Good Health and Well Being ,Coccidioidomycosis ,Community-acquired pneumonia ,Valley fever ,Biomedical and clinical sciences - Abstract
IntroductionCoccidioidomycosis is a fungal infection endemic in the southwestern United States (US). Primary pulmonary coccidioidomycosis (PPC) is a leading cause of community-acquired pneumonia (CAP) in this region, although its diagnosis is often delayed, leading to lag in antifungal treatment and subsequent morbidity. The impact of early empiric antifungal therapy as part of treatment for CAP in endemic areas on clinical outcomes is unknown.MethodsPhase IV randomized, double-blind, placebo-controlled trial in individuals aged 18 years or older with CAP who met all eligibility criteria in Coccidioides endemic regions in the US. Eligible participants with CAP were randomized to receive either fluconazole (400 mg daily) or matching placebo for 42 days and were subsequently monitored for clinical resolution of their illness.ObjectivesThe primary objective was to assess the clinical response of early empiric antifungal therapy with fluconazole through Day 22 in subjects with PPC who were adherent to the study intervention. Secondary objectives included: assessments of the impact of early empiric antifungal therapy with fluconazole through Day 22 and 43 in subjects with PPC regardless of adherence, comparisons of the clinical response and its individual components over time by treatment group in subjects with PPC, assessments of days lost from work or school, hospitalization, and all-cause mortality.DiscussionThis trial was halted early due to slow enrollment (72 participants in one year, 33 received fluconazole and 39 received placebo). Of those enrolled, eight (11%) met the study definition of PPC. The study design and challenges are discussed.
- Published
- 2021
31. How ‘green energy’ is threatening biodiversity, human health, and environmental justice: An example from the Mojave Desert, California
- Author
-
Antje Lauer, Deric English, and Melanie Helton Richardson
- Subjects
renewable energy ,Coccidioides ,Valley fever ,Joshua tree ,environmental justice ,Mojave Desert ,Environmental sciences ,GE1-350 - Abstract
ABSTRACTIn recent years, the Mojave Desert, which is known for its unique and endemic plant and animal diversity, has become a preferred area for renewable energy developments. However, an environmental impact that is not calculated into the production of green energy has emerged that not only puts an additional burden on already endangered species but also affects the quality of life for residents living in disadvantaged and underserved communities. Using the example of just another solar farm to be built on 2,300 acres of pristine desert land, we point out the negative impacts of unsustainable land development on community health and environmental justice, driven by the administration of Kern County, which promotes and prioritizes economic growth over residents’ concerns. In the eyes of the local population, several promises by the County to the community, as documented in the 2017–2020 County of Kern Strategic Goals, were broken. This study investigates the effects of unsustainable land development, particularly the threat to iconic Joshua trees (Yucca brevifolia), the increase in PM10 pollution, and the risk of contracting Valley fever for residents of two small desert communities, Boron, and Desert Lakes, in Kern County, California. This study focused on environmental justice issues due to the implementation of an ambitious renewable energy transition plan supported by the administration. This is the first study that documented the presence of the causative agent of Valley fever in soils to be disturbed for ambitious renewable energy development in eastern Kern County using a molecular, culture-independent, approach.
- Published
- 2023
- Full Text
- View/download PDF
32. Serologic Rebound after Stopping Azoles for Primary Pulmonary Coccidioidomycosis: A Case-Controlled Observational Study.
- Author
-
Shah, Priyal J., Ampel, Neil M., Girardo, Marlene E., and Blair, Janis E.
- Subjects
- *
COCCIDIOIDOMYCOSIS , *TERMINATION of treatment , *AZOLES , *PATIENT experience , *SCIENTIFIC observation , *ANTIFUNGAL agents , *ARACHNOID cysts - Abstract
Background: We sought to characterize the outcomes of patients with primary pulmonary coccidioidomycosis whose post-treatment complement fixation (CF) titer increased by more than 2 dilutions (serologic rebound) after discontinuation of antifungal treatment. Methods. We conducted a retrospective chart review of patients with primary pulmonary coccidioidomycosis and identified immunocompetent, non-pregnant adults who received antifungal treatment and then experienced a serologic rebound after treatment discontinuation. We compared these to matched controls similarly treated who did not have serologic rebound. Results. Fifty-eight patients experienced serologic rebound. Thirty (52%) of these were associated with symptoms. Nine were associated with radiographic progression. The median time to serologic rebound was 3.5 months. Antifungal treatment was reinitiated in 37 (63.7%) patients. Four of the 58 (6.9%) with rebounded serology subsequently developed extra-thoracic dissemination. Compared with matched controls, patients with rebounded serology were more likely to have post-treatment symptoms, reinitiation of antifungal therapy, and a longer duration of clinical follow-up. However, they were not more likely to experience extra-thoracic dissemination. Conclusion: Serological rebound, manifested in at least 2-dilution rise of CF titer following antifungal treatment of primary pulmonary coccidioidomycosis, was uncommon, but resulted in longer clinical follow-up. Continued monitoring of such patients is important to identify the patients who develop subsequent symptoms, as well as extra-thoracic dissemination. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
33. Disseminated cutaneous coccidioidomycosis masquerading as acne keloidalis nuchae
- Author
-
Iesha Ticknor, BS, John Jay Cadavona, MD, Keith D. Roby, MD, and David G. Cotter, MD, PhD
- Subjects
acne keloidalis nuchae ,Coccidioides immitus ,cutaneous coccidioidomycosis ,fungal infection ,valley fever ,Dermatology ,RL1-803 - Published
- 2023
- Full Text
- View/download PDF
34. Mitochondrial genomes of the human pathogens Coccidioides immitis and Coccidioides posadasii
- Author
-
de Melo Teixeira, Marcus, Lang, B Franz, Matute, Daniel R, Stajich, Jason E, and Barker, Bridget M
- Subjects
Biological Sciences ,Genetics ,Infectious Diseases ,Rare Diseases ,Valley Fever ,Humans ,Coccidioides ,Phylogeny ,Genome ,Mitochondrial ,Coccidioidomycosis ,Valley fever ,Onygenales ,coccidioidomycosis ,mitochondrial genomes ,phylogenetics ,fungal pathogen ,group I and II introns ,Biochemistry and cell biology ,Statistics - Abstract
Fungal mitochondrial genomes encode genes involved in crucial cellular processes, such as oxidative phosphorylation and mitochondrial translation, and the molecule has been used as a molecular marker for population genetics studies. Coccidioides immitis and C. posadasii are endemic fungal pathogens that cause coccidioidomycosis in arid regions across both American continents. To date, approximately 150 Coccidioides isolates have been sequenced to infer patterns of variation in nuclear genomes. However, less attention has been given to the mitochondrial genomes of Coccidioides. In this report, we describe the assembly and annotation of mitochondrial reference genomes for two representative strains of C. posadasii and C. immitis, as well as assess population variation among 77 selected genomes. The sizes of the circular-mapping molecules are 68.2 Kb in C. immitis and 75.1 Kb in C. posadasii. We identify 14 mitochondrial protein-coding genes common to most fungal mitochondria, which are largely syntenic across different populations and species of Coccidioides. Both Coccidioides species are characterized by a large number of group I and II introns, harboring twice the number of elements as compared to closely related Onygenales. The introns contain complete or truncated ORFs with high similarity to homing endonucleases of the LAGLIDADG and GIY-YIG families. Phylogenetic comparisons of mitochondrial and nuclear genomes show extensive phylogenetic discordance suggesting that the evolution of the two types of genetic material is not identical. This work represents the first assessment of mitochondrial genomes among isolates of both species of Coccidioides, and provides a foundation for future functional work.
- Published
- 2021
35. Coccidioidomycosis: Microenvironmental lung signals controlling infection
- Author
-
Delgadillo Miranda, Nadia Esmeralda
- Subjects
Immunology ,Coccidioides ,histology ,Immune ,Innate ,sequencing ,Valley fever - Abstract
Valley fever, caused by inhaling the fungal pathogen Coccidioides, presents asignificant public health concern. Coccidioides grows in the soil as mycelia segments anddifferentiates into arthroconidia (spores) under dry conditions. When the soil is disruptedand aerosolized, it can be inhaled and cause life-threatening lung infections. Originallynative to California, Arizona, Mexico, and parts of Central and South America,Coccidioides has expanded due to climate change, reaching non-endemic areas such asWashington State and predicted to advance further into the central United States. Despite60% of patients being asymptomatic or displaying minimal disease, the remaining 40%face prolonged health complications. Attempts to develop a human vaccine have beenhindered by gaps in understanding how the fungus interacts with the immune system andthe lung microenvironment. Pro-inflammatory and anti-fungal responses offer protection,yet the mechanism and cellular details are largely unexplored. Alveolar macrophages,acting as the frontline defense in the lungs, are thought to play a pivotal role in initiating apro-inflammatory response crucial for the clearance of Coccidioides. Neutrophils, the mostabundant cells in the body, exhibit rapid reactivity to microbes throughout the human body.These primary cell types are followed by the recruitment of macrophages to infection sites,contributing to an effective immune response. Considering these intricate interactions, mythesis focuses on investigating the initial immunological response of neutrophils andmacrophages and developing comprehensive protocols to explore granulomas formationand disease. This thesis work aimed to unravel the complexities of how the immune systemregulates Coccidioides infections, offering valuable insights for the development ofvaccines and therapeutic strategies.
- Published
- 2024
36. The mitochondrial genomes of the human pathogens Coccidioides immitis and C. posadasii.
- Author
-
de Melo Teixeira, Marcus, Lang, B, Matute, Daniel, Barker, Bridget, and Stajich, Jason
- Subjects
Coccidioides ,Onygenales ,Valley fever ,coccidioidomycosis ,fungal pathogen ,group I and II introns ,mitochondrial genomes ,phylogenetics - Abstract
Fungal mitochondrial genomes encode genes involved in crucial cellular processes, such as oxidative phosphorylation and mitochondrial translation, and the molecule has been used as a molecular marker for population genetics studies. Coccidioides immitis and C. posadasii are endemic fungal pathogens that cause coccidioidomycosis in arid regions across both American continents. To date, approximately 150 Coccidioides isolates have been sequenced to infer patterns of variation of nuclear genomes. However, less attention has been given to the mitochondrial genomes of Coccidioides. In this report, we describe the assembly and annotation of mitochondrial reference genomes for two representative strains of C. posadasii and C. immitis, as well as assess population variation among 77 selected genomes. The sizes of the circular-mapping molecules are 68.2 Kb in C. immitis and 75.1 Kb in C. posadasii. We identify fourteen mitochondrial protein-coding genes common to most fungal mitochondria, which are largely syntenic across different populations and species of Coccidioides. Both Coccidioides species are characterized by a large number of group I and II introns, harboring twice the number of elements as compared to closely related Onygenales. The introns contain complete or truncated ORFs with high similarity to homing endonucleases of the LAGLIDADG and GIY-YIG families. Phylogenetic comparisons of mitochondrial and nuclear genomes show extensive phylogenetic discordance suggesting that the evolution of the two types of genetic material is not identical. This work represents the first assessment of mitochondrial genomes among isolates of both species of Coccidioides, and provides a foundation for future functional work.
- Published
- 2021
37. Clinical and Economic Burden of Valley Fever in Arizona: An Incidence-Based Cost-of-Illness Analysis
- Author
-
Grizzle, Amy J, Wilson, Leslie, Nix, David E, and Galgiani, John N
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Biodefense ,Infectious Diseases ,Lung ,Prevention ,Vaccine Related ,Pneumonia ,Burden of Illness ,Emerging Infectious Diseases ,Infection ,Good Health and Well Being ,Arizona ,coccidioidomycosis ,cost-of-illness ,economic analysis ,Valley fever ,Clinical sciences ,Medical microbiology - Abstract
BackgroundCoccidioidomycosis, ie, Valley fever, is an important fungal infection in the Southwest, with half to two thirds of all cases occurring in Arizona. This endemic respiratory disease can range from primary uncomplicated pneumonia to disseminated infection such as meningitis with chronic pulmonary complications. Valley fever diagnoses have risen over recent years and cause substantial morbidity and economic burden in Arizona.MethodsWe estimated the lifetime cost-of-illness associated with all cases of Valley fever diagnosed in 2019 in Arizona. Natural history of the disease was determined from literature and expert opinion and assigned costs from national data sources to determine lifetime direct and indirect costs (work loss).ResultsTotal lifetime costs of $736 million were estimated for the 10 359 cases of Valley fever diagnosed in Arizona in 2019. Direct costs of $671 million accounted for over 90% of expenditures, with $65 million in indirect costs. Disseminated infection produces the highest economic burden at $1.26 million direct and $137 400 indirect costs per person. The lowest Valley fever lifetime costs were for cases of primary uncomplicated pneumonia with $23 200 in direct costs and $1300 in lost wages. The average lifetime direct costs across all Valley fever manifestations are $64 800 per person diagnosed in Arizona in 2019 and $6300 for indirect costs.ConclusionsValley fever is responsible for substantial economic burden in Arizona. Our estimates underscore the value of supporting research into developing more rapid diagnostic tests, better therapies, and ultimately a preventative vaccine to address this important public health problem in Arizona.
- Published
- 2021
38. Coccidioidal Hepatic Abscess in a Patient With Disseminated Coccidioidomycosis: A Case Report
- Author
-
Raza, Nadia, Nasrawi, Faisal, Heidari, Arash, Kuran, Rasha, Amin, Navinchandra, and Johnson, Royce
- Subjects
Microbiology ,Biological Sciences ,Biomedical and Clinical Sciences ,Clinical Sciences ,Lung ,Rare Diseases ,Infectious Diseases ,Digestive Diseases ,Valley Fever ,Liver Disease ,Aetiology ,2.1 Biological and endogenous factors ,Infection ,Antifungal Agents ,Coccidioides ,Coccidioidomycosis ,Humans ,Liver Abscess ,Male ,coccidioidomycosis ,disseminated coccidioidomycosis ,hepatic abscess ,coccidioidomycosis involving liver - Abstract
Coccidioidomycosis is an infection caused by inhalation of arthroconidia of Coccidioides. Forty percent of patients will develop mild and self-limited respiratory infection, and a small fraction of these individuals will develop extrapulmonary disseminated disease. This is the case of a patient with a known history of disseminated coccidioidomycosis, who initially presented for symptoms of persistent pneumonia. On evaluation, the patient was found to have a hepatic abscess for which he underwent percutaneous drainage. Culture grew Coccidioides immitis, and the patient was treated with systemic antifungal. This is a rare case of disseminated coccidioidomycosis in the liver.
- Published
- 2021
39. A Case of Disseminated Coccidioidomycosis: When the Treasure Chest Wall Opened
- Author
-
Dhital, Sandhya, Raza, Nadia, and Heidari, Arash
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Lung ,Rare Diseases ,Vaccine Related ,Prevention ,Biodefense ,Infectious Diseases ,2.1 Biological and endogenous factors ,Aetiology ,Adult ,Coccidioides ,Coccidioidomycosis ,Humans ,Lymph Nodes ,Male ,Skin ,Thoracic Wall ,coccidioidomycosis ,valley fever ,fungal infection ,dissemination ,soft tissue infection - Abstract
Coccidioidomycosis is an infection caused by soil-dwelling fungi, Coccidioides, that are endemic to the southwestern United States, northern Mexico, and scattered areas of Latin America. It typically presents with pulmonary manifestations that resemble symptoms of bronchitis, pneumonia, and the flu. Extrapulmonary manifestations that involve the skin, lymph nodes, bones, and joints have also been well described, but disseminated coccidioidomycosis initially presenting as chest wall infection without pulmonary symptoms is not. In this article, we present a case of a 33-year-old man who presented with chest wall swelling and eventually diagnosed with chest wall abscesses due to disseminated coccidioidomycosis. We propose that consideration of disseminated coccidioidomycosis in nonresolving swelling, mass, lesions, or abscess especially in endemic areas for coccidioidomycosis and in travelers to the endemic area may prevent the progression and further complications of coccidioidomycosis.
- Published
- 2021
40. The Known Unknowns of the Immune Response to Coccidioides
- Author
-
Ward, Rebecca A, Thompson, George R, Villani, Alexandra-Chloé, Li, Bo, Mansour, Michael K, Wuethrich, Marcel, Tam, Jenny M, Klein, Bruce S, and Vyas, Jatin M
- Subjects
Microbiology ,Biological Sciences ,Orphan Drug ,Valley Fever ,Biodefense ,Infectious Diseases ,Rare Diseases ,Lung ,Prevention ,Vaccine Related ,Emerging Infectious Diseases ,Good Health and Well Being ,coccidioidomycosis ,innate immunity ,adaptive immunity ,respiratory epithelium ,vaccine strategies ,single-cell RNA sequencing ,spatial transcriptomics - Abstract
Coccidioidomycosis, otherwise known as Valley Fever, is caused by the dimorphic fungi Coccidioides immitis and C. posadasii. While most clinical cases present with self-limiting pulmonary infection, dissemination of Coccidioides spp. results in prolonged treatment and portends higher mortality rates. While the structure, genome, and niches for Coccidioides have provided some insight into the pathogenesis of disease, the underlying immunological mechanisms of clearance or inability to contain the infection in the lung are poorly understood. This review focuses on the known innate and adaptive immune responses to Coccidioides and highlights three important areas of uncertainty and potential approaches to address them. Closing these gaps in knowledge may enable new preventative and therapeutic strategies to be pursued.
- Published
- 2021
41. A chromosomal-level reference genome of the widely utilized Coccidioides posadasii laboratory strain “Silveira”
- Author
-
de Melo Teixeira, Marcus, Stajich, Jason E, Sahl, Jason W, Thompson, George R, Blackmon, Austin V, Mead, Heather L, Keim, Paul, and Barker, Bridget M
- Subjects
Microbiology ,Biological Sciences ,Bioinformatics and Computational Biology ,Genetics ,Human Genome ,Emerging Infectious Diseases ,Infectious Diseases ,Valley Fever ,Biotechnology ,Rare Diseases ,Biodefense - Abstract
ABSTRACT Coccidioidomycosis is a common fungal disease that is endemic to arid and semi-arid regions of both American continents. Coccidioides immitis and C. posadasii are the etiological agents of the disease, also known as Valley Fever. For several decades, the C. posadasii strain Silveira has been used widely in vaccine studies, is the source strain for production of diagnostic antigens, and is a widely used experimental strain for functional studies. In 2009, the genome was sequenced using Sanger sequencing technology, and a draft assembly and annotation was made available. In the current study, the genome of the Silveira strain was sequenced using Single Molecule Real Time Sequencing (SMRT) PacBio technology, assembled into chromosomal-level contigs, genotyped, and the genome was reannotated using sophisticated and curated in silico tools. This high-quality genome sequencing effort has improved our understanding of chromosomal structure, gene set annotation, and lays the groundwork for identification of structural variants (e.g. transversions, translocations, and copy number variants), assessment of gene gain and loss, and comparison of transposable elements in future phylogenetic and population genomics studies.
- Published
- 2021
42. Discovery of a Unique Set of Dog-Seroreactive Coccidioides Proteins Using Nucleic Acid Programmable Protein Array
- Author
-
Megan A. Koehler, Lusheng Song, Francisca J. Grill, Lisa F. Shubitz, Daniel A. Powell, John N. Galgiani, Marc J. Orbach, Edward J. Robb, Yunro Chung, Stacy A. Williams, Vel Murugan, Jin-gyoon Park, Joshua LaBaer, Douglas F. Lake, and D. Mitchell Magee
- Subjects
coccidioidomycosis ,valley fever ,dogs ,antibodies ,diagnostics ,Biology (General) ,QH301-705.5 - Abstract
Valley Fever (VF), caused by fungi in the genus Coccidioides, is a prevalent disease in southwestern and western parts of the United States that affects both humans and animals, such as dogs. Although the immune responses to infection with Coccidioides spp. are not fully characterized, antibody-detection assays are used in conjunction with clinical presentation and radiologic findings to aid in the diagnosis of VF. These assays often use Complement Fixation (CF) and Tube Precipitin (TP) antigens as the main targets of IgG and IgM reactivity, respectively. Our group previously reported evidence of over 800 genes expressed at the protein level in C. posadasii. However, antibody reactivity to the majority of these proteins has never been explored. Using a new, high-throughput screening technology, the Nucleic Acid Programmable Protein Array (NAPPA), we screened serum specimens from dogs against 708 of these previously identified proteins for IgG reactivity. Serum from three separate groups of dogs was analyzed and revealed a small panel of proteins to be further characterized for immuno-reactivity. In addition to CF/CTS1 antigen, sera from most infected dogs showed antibody reactivity to endo-1,3-betaglucanase, peroxisomal matrix protein, and another novel reactive protein, CPSG_05795. These antigens may provide additional targets to aid in antibody-based diagnostics.
- Published
- 2024
- Full Text
- View/download PDF
43. Galleria mellonella Model of Coccidioidomycosis for Drug Susceptibility Tests and Virulence Factor Identification
- Author
-
Matthew Mendoza Barker, Sarah Saeger, Althea Campuzano, Jieh-Juen Yu, and Chiung-Yu Hung
- Subjects
Coccidioides ,Valley Fever ,fungi ,Galleria mellonella ,drug susceptibility ,virulence factors ,Biology (General) ,QH301-705.5 - Abstract
Coccidioidomycosis (CM) can manifest as respiratory and disseminated diseases that are caused by dimorphic fungal pathogens, such as Coccidioides species. The inhaled arthroconidia generated during the saprobic growth phase convert into multinucleated spherules in the lungs to complete the parasitic lifecycle. Research on coccidioidal virulence and pathogenesis primarily employs murine models typically associated with low lethal doses (LD100 < 100 spores). However, the Galleria model has recently garnered attention due to its immune system bearing both structural and functional similarities to the innate system of mammals. Our findings indicate that Coccidioides posadasii can convert and complete the parasitic cycle within the hemocoel of the Galleria larva. In Galleria, the LD100 is between 0.5 and 1.0 × 106 viable spores for the clinical isolate Coccidioides posadasii C735. Furthermore, we demonstrated the suitability of this model for in vivo antifungal susceptibility tests to validate the bioreactivity of newly discovered antifungals against Coccidioides. Additionally, we utilized this larva model to screen a Coccidioides posadasii mutant library showing attenuated virulence. Similarly, the identified attenuated coccidioidal mutants displayed a loss of virulence in a commonly used murine model of coccidioidomycosis. In this study, we demonstrated that Galleria larvae can be applied as a model for studying Coccidioides infection.
- Published
- 2024
- Full Text
- View/download PDF
44. Epidemiology of Coccidioidomycosis in the Veterans Health Administration, 2013–2022.
- Author
-
Lucero-Obusan, Cynthia, Deka, Rishi, Schirmer, Patricia, Oda, Gina, and Holodniy, Mark
- Subjects
- *
VETERANS' health , *EPIDEMIOLOGY , *RACE , *ELECTRONIC health records , *MYCOSES - Abstract
We describe the epidemiology of coccidioidomycosis among a national cohort of Veterans. Using electronic health record data from adults tested for coccidioidomycosis between 1 January 2013 and 31 December 2022, we analyzed differences in baseline demographics (age, sex, race/ethnicity, birth country, comorbidities, residence, and Charlson Comorbidity Index score) between 4204 coccidioidomycosis-test-positive and 63,322 test-negative Veterans. Log-binomial regression models with adjusted risk ratios (aRRs) were used to evaluate risk factors associated with coccidioidomycosis including dissemination, hospitalization, and mortality. Case counts and incidence rates were highest in select counties in Arizona and California where Coccidioides is endemic. Coccidioidomycosis-positive Veterans were younger, more likely to be male, and Philippine-born. The risk factors most highly associated with being coccidioidomycosis-positive included Native Hawaiian/Pacific Islander (aRR 1.068 [95%CI: 1.039–1.098]), Asian (aRR 1.060 [95%CI: 1.037–1.083]), Black (aRR 1.029 [95%CI: 1.022–1.036]), American Indian/Alaska Native (aRR 1.026 [95%CI: 1.004–1.048]) race, and Hispanic/Latino ethnicity (aRR 1.021 [95%CI: 1.013–1.028]). Black race (aRR: 1.058 [95%CI: 1.037–1.081]) and Hispanic/Latino ethnicity (aRR 1.018 [95%CI: 1.0003–1.036]) were also associated with disseminated coccidioidomycosis, strengthening the evidence for the association of coccidioidomycosis, including severe infections, with specific racial and ethnic groups. There were no statistically significant differences in hospitalization within 45 days of testing or 30-day all-cause mortality. Improving our understanding of coccidioidomycosis risk factors is important for targeted prevention strategies and to reduce delays in diagnosis and ineffective treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
45. Coccidioidomycosis Granulomas Informed by Other Diseases: Advancements, Gaps, and Challenges.
- Author
-
Miranda, Nadia and Hoyer, Katrina K.
- Subjects
- *
GRANULOMA , *COCCIDIOIDOMYCOSIS , *CHRONIC granulomatous disease , *RESPIRATORY diseases , *COMMUNICABLE diseases - Abstract
Valley fever is a respiratory disease caused by a soil fungus, Coccidioides, that is inhaled upon soil disruption. One mechanism by which the host immune system attempts to control and eliminate Coccidioides is through granuloma formation. However, very little is known about granulomas during Coccidioides infection. Granulomas were first identified in tuberculosis (TB) lungs as early as 1679, and yet many gaps in our understanding of granuloma formation, maintenance, and regulation remain. Granulomas are best defined in TB, providing clues that may be leveraged to understand Coccidioides infections. Granulomas also form during several other infectious and spontaneous diseases including sarcoidosis, chronic granulomatous disease (CGD), and others. This review explores our current understanding of granulomas, as well as potential mechanisms, and applies this knowledge to unraveling coccidioidomycosis granulomas. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
46. Coccidioidomycosis and Host Microbiome Interactions: What We Know and What We Can Infer from Other Respiratory Infections.
- Author
-
Tejeda-Garibay, Susana and Hoyer, Katrina K.
- Subjects
- *
TUBERCULOSIS , *RESPIRATORY infections , *CHRONIC obstructive pulmonary disease , *CYSTIC fibrosis , *LUNG diseases - Abstract
Between 70 and 80% of Valley fever patients receive one or more rounds of antibiotic treatment prior to accurate diagnosis with coccidioidomycosis. Antibiotic treatment and infection (bacterial, viral, fungal, parasitic) often have negative implications on host microbial dysbiosis, immunological responses, and disease outcome. These perturbations have focused on the impact of gut dysbiosis on pulmonary disease instead of the implications of direct lung dysbiosis. However, recent work highlights a need to establish the direct effects of the lung microbiota on infection outcome. Cystic fibrosis, chronic obstructive pulmonary disease, COVID-19, and M. tuberculosis studies suggest that surveying the lung microbiota composition can serve as a predictive factor of disease severity and could inform treatment options. In addition to traditional treatment options, probiotics can reverse perturbation-induced repercussions on disease outcomes. The purpose of this review is to speculate on the effects perturbations of the host microbiome can have on coccidioidomycosis progression. To do this, parallels are drawn to aa compilation of other host microbiome infection studies. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
47. Disseminated Coccidioidomycosis to the Gallbladder
- Author
-
Grewal, Kulraj, Bajaj, Tushar, Petersen, Greti, Munoz, Augustine, Froush, Arman, and Heidari, Arash
- Subjects
Biological Sciences ,Biomedical and Clinical Sciences ,Microbiology ,Clinical Sciences ,Medical Microbiology ,Rare Diseases ,Emerging Infectious Diseases ,Biodefense ,Prevention ,Vaccine Related ,Valley Fever ,Infectious Diseases ,Pain Research ,Administration ,Intravenous ,Amphotericin B ,Cholecystectomy ,Laparoscopic ,Cholecystitis ,Coccidioides ,Coccidioidomycosis ,Drainage ,Humans ,Immunocompromised Host ,Male ,Middle Aged ,Spores ,Fungal ,Treatment Outcome ,coccidioidomycosis ,gallbladder ,fungus ,endemic mycosis - Abstract
Coccidioidomycosis is an infection caused by inhalation of arthroconidia produced by dimorphic fungi in the genus Coccidioides. Forty percent of patients will develop an influenza-like illness with symptoms suggestive of a mild and self-limited respiratory infection; however, 5% of these individuals will develop extrapulmonary disseminated disease. An immunocompromised patient presented with right upper quadrant pain, ultrasound with pericholecystic fluid, in which a percutaneous cholecystostomy contained biliary fluid that grew the fungus Coccidioides immitis. Patient was initiated on intravenous amphotericin therapy and was followed closely with postoperative bile drainage with eventual laparoscopic cholecystectomy. We present a very rare case of disseminated coccidioidomycosis to the gallbladder.
- Published
- 2020
48. Differential Thermotolerance Adaptation between Species of Coccidioides
- Author
-
Mead, Heather L, Hamm, Paris S, Shaffer, Isaac N, de Melo Teixeira, Marcus, Wendel, Christopher S, Wiederhold, Nathan P, Thompson, George R, Muñiz-Salazar, Raquel, Castañón-Olivares, Laura Rosio, Keim, Paul, Plude, Carmel, Terriquez, Joel, Galgiani, John N, Orbach, Marc J, and Barker, Bridget M
- Subjects
Biological Sciences ,Ecology ,Valley Fever ,Biodefense ,Emerging Infectious Diseases ,Infectious Diseases ,Prevention ,Vaccine Related ,Rare Diseases ,Orphan Drug ,coccidioidomycosis ,fungal pathogen ,phenotypic variation ,growth rate ,valley fever ,Microbiology - Abstract
Coccidioidomycosis, or Valley fever, is caused by two species of dimorphic fungi. Based on molecular phylogenetic evidence, the genus Coccidioides contains two reciprocally monophyletic species: C. immitis and C. posadasii. However, phenotypic variation between species has not been deeply investigated. We therefore explored differences in growth rate under various conditions. A collection of 39 C. posadasii and 46 C. immitis isolates, representing the full geographical range of the two species, was screened for mycelial growth rate at 37 °C and 28 °C on solid media. The radial growth rate was measured for 16 days on yeast extract agar. A linear mixed effect model was used to compare the growth rate of C. posadasii and C. immitis at 37 °C and 28 °C, respectively. C. posadasii grew significantly faster at 37 °C, when compared to C. immitis; whereas both species had similar growth rates at 28 °C. These results indicate thermotolerance differs between these two species. As the ecological niche has not been well-described for Coccidioides spp., and disease variability between species has not been shown, the evolutionary pressure underlying the adaptation is unclear. However, this research reveals the first significant phenotypic difference between the two species that directly applies to ecological research.
- Published
- 2020
49. Structural characterization and evolutionary analyses of the Coccidioides immitis and Coccidioides posadasii mitochondrial genomes
- Author
-
de Melo Teixeira, Marcus, Lang, B Franz, Matute, Daniel R, Stajich, Jason E, and Barker, Bridget
- Subjects
Biological Sciences ,Genetics ,Emerging Infectious Diseases ,Infectious Diseases ,Rare Diseases ,Valley Fever - Abstract
Fungal mitochondrial genomes encode for genes involved in crucial cellular processes, such as oxidative phosphorylation and mitochondrial translation, and these genes have been used as molecular markers for population genetics studies. Coccidioides immitis and C. posadasii are endemic fungal pathogens that cause coccidioidomycosis in arid regions across both American continents. To date, almost one hundred Coccidioides strains have been sequenced. The focus of these studies has been exclusively to infer patterns of variation of nuclear genomes (nucDNA). However, their mitochondrial genomes (mtDNA) have not been studied. In this report, we describe the assembly and annotation of mitochondrial reference genomes for two representative strains of C. posadasii and C. immitis , as well as assess population variation among 77 published genomes. The circular-mapping mtDNA molecules are 68.2 Kb in C. immitis and 75.1 Kb in C. posadasii . We identified the fourteen mitochondrial protein-coding genes common to most fungal mitochondria, including genes encoding the small and large ribosomal RNAs ( rns and rnl ), the RNA subunit of RNAse P ( rnp B), and 26 tRNAs organized in polycistronic transcription units, which are mostly syntenic across different populations and species of Coccidioides . Both Coccidioides species are characterized by a large number of group I and II introns, harboring twice the number of elements as compared to closely related Onygenales. The introns contain complete or truncated ORFs with high similarity to homing endonucleases of the LAGLIDADG and GIY-YIG families. Phylogenetic comparison of the mtDNA and nucDNA genomes shows discordance, possibly due to differences in patterns of inheritance. In summary, this work represents the first complete assessment of mitochondrial genomes among several isolates of both species of Coccidioides , and provides a foundation for future functional work.
- Published
- 2020
50. SUBA-Itraconazole Therapy for Coccidioidomycosis Refractory or Intolerant to Fluconazole (SITRIS)
- Author
-
Mayne Pharma International Pty Ltd and George R Thompson, Associate Professor of Medicine
- Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.